Description: Willow Biosciences is a Canadian based, research and development company. It will focus on creating synthetic biology solution from gene discovery to cannabinoid commercialization.
Home Page: www.willowbio.com
WLLW Technical Analysis
202, 1201-5th Street SW
Calgary,
AB
T2R 0Y6
Canada
Phone:
403 910 5140
Officers
| Name | Title |
|---|---|
| Dr. Peter Seufer-Wasserthal Ph.D. | Pres, CEO & Chairman |
| Mr. Travis Doupe | Chief Financial Officer |
| Dr. Chris Savile | Chief Operations Officer |
| Mr. Simon Hickling Ph.D. | Sr. VP of Bus. Devel. |
| Dr. Trish Choudhary | VP of R&D |
| Mr. Troy T. Talkkari | VP of Corp. Devel. |
| Mr. Sanjib Singh Gill L.L.B. | Corp. Sec. |
Exchange: TO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 67.5676 |
|---|---|
| Trailing PE: | 4 |
| Price-to-Book MRQ: | 0.7107 |
| Price-to-Sales TTM: | 42.5288 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 49 |